Janus kinase 1 (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "Janus kinase 1" in French language version.

refsWebsite

Global rank French rank

2,393^rd place

506^th place

1,626^th place

2,018^th place

4^th place

12^th place

1sciencedirect.com

149^th place

80^th place

low place

5,364^th place

ensembl.org

May2017.archive.ensembl.org

GRCh38: Ensembl release 89: ENSG00000162434 - Ensembl, May 2017
GRCm38: Ensembl release 89: ENSMUSG00000028530 - Ensembl, May 2017

nih.gov

ncbi.nlm.nih.gov

« Publications PubMed pour l'Homme », sur National Center for Biotechnology Information, U.S. National Library of Medicine
« Publications PubMed pour la Souris », sur National Center for Biotechnology Information, U.S. National Library of Medicine

rupress.org

jem.rupress.org

Flex E, Petrangeli V, Stella L et al. Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia, J Exp Med, 2008;205:751–758.

sciencedirect.com

Stark GR, Darnell JE Jr, The JAK-STAT pathway at twenty, Immunity, 2012;36:503–514

thelancet.com

Vermeire, S, Schreiber, S, Petryka, R et al. Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial, Lancet, 2017;389:266–275
Burmester G, Kremer J, Van den Bosch F et al. Safety and efficacy of upadacitinib in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying anti-rheumatic drugs (SELECT-NEXT): a randomised, double-blind, placebo-controlled phase 3 trial, Lancet, 2018;391:2503–2512
Simpson EL, Sinclair R, Forman S et al. Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial, Lancet, 2020;396:255-266